{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:44:26Z","timestamp":1770630266299,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jcrc.2025.155038","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T04:11:54Z","timestamp":1739679114000},"page":"155038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Multisystem hemodynamic effects of terlipressin in cirrhosis: A scoping review"],"prefix":"10.1016","volume":"87","author":[{"given":"Jeremy","family":"Skvarce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Oro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloni","family":"Sachar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Pat","family":"Harnegie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aanchal","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina C.","family":"Lindenmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Siuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcrc.2025.155038_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.14218\/JCTH.2020.00011","article-title":"Management of hepatorenal syndrome: a review","volume":"8","author":"Tariq","year":"2020","journal-title":"J Clin Transl Hepatol"},{"issue":"45","key":"10.1016\/j.jcrc.2025.155038_bb0010","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.3748\/wjg.v27.i45.7831","article-title":"In-hospital mortality of hepatorenal syndrome in the United States: nationwide inpatient sample","volume":"27","author":"Kaewput","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155038_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13696998.2019.1580201","article-title":"The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records","volume":"22","author":"Jamil","year":"2019","journal-title":"J Med Econ"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155038_bb0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/gastroent14040031","article-title":"Terlipressin for the prevention and treatment of renal decline in hepatorenal syndrome: a drug profile","volume":"14","author":"Ayyad","year":"2023","journal-title":"Gastroenterol Insights"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155038_bb0025","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.24519","article-title":"Terlipressin: an asset for hepatologists!","volume":"54","author":"Sarin","year":"2011","journal-title":"Hepatology (Baltim, Md)"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155038_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000890","article-title":"Role of terlipressin in patients with hepatorenal syndrome-acute kidney injury admitted to the ICU: a substudy of the CONFIRM trial","volume":"5","author":"Karvellas","year":"2023","journal-title":"Crit Care Explor"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155038_bb0035","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American association for the study of liver diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155038_bb0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcrc.2025.155038_bb0045","article-title":"Which vasoactive medications are most effective for hepatorenal syndrome?","volume":"2022","author":"Hila Calev","year":"2022","journal-title":"NEJM J Watch"},{"key":"10.1016\/j.jcrc.2025.155038_bb0050","series-title":"Organ-specific and systemic hemodynamic effects of terlipressin administration in patients with cirrhosis","author":"Siuba","year":"2023"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12072-022-10416-6","article-title":"Low-dose continuous terlipressin infusion is effective and safer than intravenous bolus injections in reducing portal pressure and control of acute variceal bleeding","volume":"17","author":"Arora","year":"2023","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(97)80428-X","article-title":"Time profile of the haemodynamic effects of terlipressin in portal hypertension","volume":"26","author":"Escorsell","year":"1997","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155038_bb0065","first-page":"755","article-title":"Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver","volume":"16","author":"Badruddin","year":"2006","journal-title":"J Coll Physicians Surg Pak"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2005.41381.x","article-title":"Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison","volume":"100","author":"Baik","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jcrc.2025.155038_bb0075","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1440-1746.2005.03902.x","article-title":"Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis","volume":"20","author":"Kalambokis","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155038_bb0080","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1478-3231.2010.02322.x","article-title":"Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis","volume":"30","author":"Kalambokis","year":"2010","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155038_bb0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/00365520310008728","article-title":"Effect of terlipressin on blood volume distribution in patients with cirrhosis","volume":"39","author":"Kiszka-Kanowitz","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155038_bb0090","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/003655202317316132","article-title":"Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis","volume":"37","author":"Lin","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000197942","article-title":"The effect of vasopressin and triglycyl lysine vasopressin (Glypressin) on the splanchnic circulation in cirrhotic patients with portal hypertension","volume":"14","author":"Rabol","year":"1976","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1440-1746.2004.03226.x","article-title":"Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study","volume":"19","author":"Therapondos","year":"2004","journal-title":"J Gastroenterol Hepatol Aust"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155038_bb0115","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/BF02088736","article-title":"Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselective \u03b2-blocker","volume":"41","author":"Vachiery","year":"1996","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155038_bb0120","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/MEG.0b013e32833a4822","article-title":"Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis","volume":"22","author":"Krag","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155038_bb0125","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1572-0241.2001.03705.x","article-title":"Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis","volume":"96","author":"Lee","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0676.2000.020001051.x","article-title":"Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients","volume":"20","author":"M\u00f8ller","year":"2000","journal-title":"Liver"},{"issue":"11","key":"10.1016\/j.jcrc.2025.155038_bb0135","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis","volume":"24","author":"Narahara","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jcrc.2025.155038_bb0140","first-page":"1923","article-title":"Prophylactic terlipressin infusion for severe postreperfusion syndrome in patients undergoing deceased donor liver transplantation: the TIPS-DDLT randomized controlled trial","volume":"109","author":"Zhang","year":"2023","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0145","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1572-0241.2004.40665.x","article-title":"Hemodynamic effects of terlipressin and high somatostatin dose during acute variceal bleeding in nonresponders to the usual somatostatin dose","volume":"100","author":"Villanueva","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155038_bb0150","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-6774","article-title":"The pharmacodynamic effect of terlipressin versus high-dose octreotide in reducing hepatic venous pressure gradient: a randomized controlled trial","volume":"9","author":"Li","year":"2021","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(00)80392-X","article-title":"Terlipressin is more effective in deceasing variceal pressure than portal pressure in cirrhotic patients","volume":"32","author":"Romero","year":"2000","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0160","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcrc.2025.155038_bb0165","first-page":"19","article-title":"Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial","author":"Mahdy","year":"2019","journal-title":"BMC Anesthesiol"},{"issue":"8","key":"10.1016\/j.jcrc.2025.155038_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13019","article-title":"Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: a randomized controlled trial","volume":"31","author":"Kandil","year":"2017","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155038_bb0175","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/CCM.0b013e3182120842","article-title":"The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function","volume":"39","author":"Mukhtar","year":"2011","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.egja.2011.10.002","article-title":"Terlipressin versus norepinephrine to counteract intraoperative paracentesis induced refractory hypotension in cirrhotic patients","volume":"28","author":"Abdullah","year":"2012","journal-title":"Egypt J Anaesth"},{"issue":"1 Pt 2","key":"10.1016\/j.jcrc.2025.155038_bb0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1746.2006.04182.x","article-title":"Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study","volume":"21","author":"Singh","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155038_bb0190","doi-asserted-by":"crossref","first-page":"G313","DOI":"10.1152\/ajpgi.00328.2019","article-title":"Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial","volume":"318","author":"Israelsen","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155038_bb0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042737-200202000-00009","article-title":"Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study","volume":"14","author":"Halimi","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/0019-5049.153037","article-title":"The haemodynamic effects of the perioperative terlipressin infusion in living donor liver transplantation: a randomised controlled study","volume":"59","author":"Ibrahim","year":"2015","journal-title":"Indian J Anaesth"},{"issue":"7","key":"10.1016\/j.jcrc.2025.155038_bb0205","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/jgh.12195","article-title":"Hemodynamic effects of continuous versus bolus infusion of terlipressin for portal hypertension: a randomized comparison","volume":"28","author":"Ding","year":"2013","journal-title":"J Gastroenterol Hepatol Aust"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155038_bb0210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jcrc.2013.02.016","article-title":"Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation","volume":"28","author":"Fayed","year":"2013","journal-title":"J Crit Care"},{"issue":"7","key":"10.1016\/j.jcrc.2025.155038_bb0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MEG.0000000000000635","article-title":"Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis","volume":"28","author":"Salman","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jcrc.2025.155038_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0003319711411704","article-title":"Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study","volume":"63","author":"Kalambokis","year":"2012","journal-title":"Angiology"},{"issue":"Suppl. 1","key":"10.1016\/j.jcrc.2025.155038_bb0225","first-page":"224","article-title":"Haemodynamic effects of triglycyl-lysine vasopressin plus nitroglycerin in patients with HBsAg-positive cirrhosis","volume":"4","author":"Lin","year":"1989","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jcrc.2025.155038_bb0230","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0168-8278(97)80456-4","article-title":"Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites","volume":"26","author":"Gadano","year":"1997","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155038_bb0235","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1872-034X.2010.00715.x","article-title":"Scintigraphic evaluation of intrapulmonary shunt in normoxemic cirrhotic patients and effects of terlipressin","volume":"40","author":"Kalambokis","year":"2010","journal-title":"Hepatol Res"},{"issue":"15","key":"10.1016\/j.jcrc.2025.155038_bb0240","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3748\/wjg.v10.i15.2278","article-title":"Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: an echocardiographic assessment","volume":"10","author":"Altintas","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/147323001204000123","article-title":"Perioperative assessment of terlipressin infusion during living donor liver transplantation","volume":"40","author":"Hong","year":"2012","journal-title":"J Int Med Res"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155038_bb0250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S1499-3872(12)60204-5","article-title":"Terlipressin improves pulmonary pressures in cirrhotic patients with pulmonary hypertension and variceal bleeding or hepatorenal syndrome","volume":"11","author":"Kalambokis","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"12","key":"10.1016\/j.jcrc.2025.155038_bb0255","first-page":"1795","article-title":"Terlipressin infusion improves the hepatic and renal blood flow assessed by doppler ultrasonography","volume":"66","author":"Popov","year":"2013","journal-title":"C R Acad Bulg Sci"},{"issue":"2","key":"10.1016\/j.jcrc.2025.155038_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0168-8278(90)90053-T","article-title":"Hemodynamic-effect of triglycyl-lysine-vasopressin (Glypressin) on intravascular esophageal variceal pressure in patients with cirrhosis - a randomized placebo controlled trial","volume":"10","author":"Cestari","year":"1990","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155038_bb0265","first-page":"604","article-title":"Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein doppler waveform","volume":"63","author":"Hussain","year":"2013","journal-title":"J Pak Med Assoc"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155038_bb0270","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1440-1746.2003.02992.x","article-title":"Comparison of doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis","volume":"18","author":"Choi","year":"2003","journal-title":"J Gastroenterol Hepatol Aust"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155038_bb0275","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.17868","article-title":"Comparison of 1-day versus 3-day intravenous terlipressin in cirrhosis patients with variceal bleeding: a pilot randomised controlled trial","volume":"59","author":"Vaishnav","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0168-8278(87)80011-9","article-title":"Hepatic blood flow determination. A comparison of 99mTc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man","volume":"4","author":"Henriksen","year":"1987","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13613-015-0085-5","article-title":"Personalizing blood pressure management in septic shock","volume":"5","author":"Kato","year":"2015","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.jcrc.2025.155038_bb0290","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.34067\/KID.0000000000000068","article-title":"Responsiveness to vasoconstrictor therapy in hepatorenal syndrome type 1","volume":"4","author":"Velez","year":"2023","journal-title":"Kidney360"},{"issue":"5","key":"10.1016\/j.jcrc.2025.155038_bb0295","doi-asserted-by":"crossref","first-page":"196","DOI":"10.14740\/jocmr4702","article-title":"Mean arterial pressure goal in critically ill patients: a meta-analysis of randomized controlled trials","volume":"14","author":"Sarkar","year":"2022","journal-title":"J Clin Med Res"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0300","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/s41598-024-56873-x","article-title":"Real-world comparison of terlipressin vs. octreotide as an adjuvant treatment in the management of variceal bleeding","volume":"14","author":"Rehman","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155038_bb0305","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1097\/MS9.0000000000001261","article-title":"Continuous vs. intermittent terlipressin infusion for portal hypertension: a systematic review and meta-analysis","volume":"85","author":"Hassan","year":"2023","journal-title":"Ann Med Surg"},{"issue":"10","key":"10.1016\/j.jcrc.2025.155038_bb0310","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/CCM.0000000000005595","article-title":"The comparative effectiveness of vasoactive treatments for hepatorenal syndrome: a systematic review and network meta-analysis","volume":"50","author":"Pitre","year":"2022","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2025.155038_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296690","article-title":"Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: a systematic review and meta-analysis","volume":"19","author":"Olson","year":"2024","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.jcrc.2025.155038_bb0320","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.34067\/KID.0000000000000132","article-title":"The effect of terlipressin on renal replacement therapy in patients with hepatorenal syndrome","volume":"4","author":"Velez","year":"2023","journal-title":"Kidney360"},{"issue":"9","key":"10.1016\/j.jcrc.2025.155038_bb0325","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jcrc.2025.155038_bb0330","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944125000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T19:24:19Z","timestamp":1741721059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944125000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":66,"alternative-id":["S0883944125000255"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155038","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multisystem hemodynamic effects of terlipressin in cirrhosis: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2025.155038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155038"}}